Uses of mesenchymal stem cells
AssigneesConsejo Superior de Investigaciones Cientificas, TiGenix, S.A.U., Universidad de Sevilla
InventorsMario DELGADO, Elena GONZALEZ-REY, Dirk BÜSCHER
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS.
Claims21
1-30. (canceled)
A method of treating severe sepsis caused by a bacterium in a human subject, comprising intravenously administering a therapeutic amount of a population of expanded adipose tissue derived stromal stem cells (eASCs) to treat severe sepsis caused by a bacterium in the subject, wherein the eASCs are allogenic with respect to the subject to be treated.
Dependencies are inferred from the claim text.